Report Detail
Global Nanomedicine and Nanobiotechnology Market Growth (Status and Outlook) 2021-2026
- RnM4357176 |
- 11 December, 2021 |
- Global |
- 103 Pages |
- LPI(LP Information) |
- Chemical & Material
According to this latest study, the 2021 growth of Nanomedicine and Nanobiotechnology will have significant change from previous year. By the most conservative estimates of global Nanomedicine and Nanobiotechnology market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Nanomedicine and Nanobiotechnology market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Nanomedicine and Nanobiotechnology market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospitals
Clinics
Research Institute
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Abbott
GE Healthcare
Johnson & Johnson
Merck
Pfizer
CombiMatrix
Celgene
Mallinckrodt
Sigma-Tau Pharmaceuticals
Teva Pharmaceutical
Nanosphere
UCB SA
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Nanomedicine and Nanobiotechnology Market Size 2016-2026
- 2.1.2 Nanomedicine and Nanobiotechnology Market Size CAGR by Region 2020 VS 2021 VS 2026
- 2.2 Nanomedicine and Nanobiotechnology Segment by Type
- 2.2.1 Nanoparticles
- 2.2.2 Nanoparticles
- 2.2.3 Nanotubes
- 2.2.4 Nanodevices
- 2.2.5 Others
- 2.3 Nanomedicine and Nanobiotechnology Market Size by Type
- 2.3.1 Global Nanomedicine and Nanobiotechnology Market Size CAGR by Type
- 2.3.2 Global Nanomedicine and Nanobiotechnology Market Size Market Share by Type (2016-2021)
- 2.4 Nanomedicine and Nanobiotechnology Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Clinics
- 2.4.3 Research Institute
- 2.5 Nanomedicine and Nanobiotechnology Market Size by Application
- 2.5.1 Global Nanomedicine and Nanobiotechnology Market Size CAGR by Application
- 2.5.2 Global Nanomedicine and Nanobiotechnology Market Size Market Share by Application (2016-2021)
3 Nanomedicine and Nanobiotechnology Market Size by Players
- 3.1 Nanomedicine and Nanobiotechnology Market Size Market Share by Players
- 3.1.1 Global Nanomedicine and Nanobiotechnology Revenue by Players (2019-2021E)
- 3.1.2 Global Nanomedicine and Nanobiotechnology Revenue Market Share by Players (2019-2021E)
- 3.2 Global Nanomedicine and Nanobiotechnology Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Nanomedicine and Nanobiotechnology by Regions
- 4.1 Nanomedicine and Nanobiotechnology Market Size by Regions (2016-2021)
- 4.2 Americas Nanomedicine and Nanobiotechnology Market Size Growth (2016-2021)
- 4.3 APAC Nanomedicine and Nanobiotechnology Market Size Growth (2016-2021)
- 4.4 Europe Nanomedicine and Nanobiotechnology Market Size Growth (2016-2021)
- 4.5 Middle East & Africa Nanomedicine and Nanobiotechnology Market Size Growth (2016-2021)
5 Americas
- 5.1 Americas Nanomedicine and Nanobiotechnology Market Size by Country (2016-2021)
- 5.2 Americas Nanomedicine and Nanobiotechnology Market Size by Type (2016-2021)
- 5.3 Americas Nanomedicine and Nanobiotechnology Market Size by Application (2016-2021)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Nanomedicine and Nanobiotechnology Market Size by Region (2016-2021)
- 6.2 APAC Nanomedicine and Nanobiotechnology Market Size by Type (2016-2021)
- 6.3 APAC Nanomedicine and Nanobiotechnology Market Size by Application (2016-2021)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Nanomedicine and Nanobiotechnology by Country (2016-2021)
- 7.2 Europe Nanomedicine and Nanobiotechnology Market Size by Type (2016-2021)
- 7.3 Europe Nanomedicine and Nanobiotechnology Market Size by Application (2016-2021)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Nanomedicine and Nanobiotechnology by Region (2016-2021)
- 8.2 Middle East & Africa Nanomedicine and Nanobiotechnology Market Size by Type (2016-2021)
- 8.3 Middle East & Africa Nanomedicine and Nanobiotechnology Market Size by Application (2016-2021)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Nanomedicine and Nanobiotechnology Market Forecast
- 10.1 Global Nanomedicine and Nanobiotechnology Forecast by Regions (2021-2026)
- 10.1.1 Global Nanomedicine and Nanobiotechnology Forecast by Regions (2021-2026)
- 10.1.2 Americas Nanomedicine and Nanobiotechnology Forecast
- 10.1.3 APAC Nanomedicine and Nanobiotechnology Forecast
- 10.1.4 Europe Nanomedicine and Nanobiotechnology Forecast
- 10.1.5 Middle East & Africa Nanomedicine and Nanobiotechnology Forecast
- 10.2 Americas Nanomedicine and Nanobiotechnology Forecast by Countries (2021-2026)
- 10.2.1 United States Nanomedicine and Nanobiotechnology Market Forecast
- 10.2.2 Canada Nanomedicine and Nanobiotechnology Market Forecast
- 10.2.3 Mexico Nanomedicine and Nanobiotechnology Market Forecast
- 10.2.4 Brazil Nanomedicine and Nanobiotechnology Market Forecast
- 10.3 APAC Nanomedicine and Nanobiotechnology Forecast by Region (2021-2026)
- 10.3.1 China Nanomedicine and Nanobiotechnology Market Forecast
- 10.3.2 Japan Nanomedicine and Nanobiotechnology Market Forecast
- 10.3.3 Korea Nanomedicine and Nanobiotechnology Market Forecast
- 10.3.4 Southeast Asia Nanomedicine and Nanobiotechnology Market Forecast
- 10.3.5 India Nanomedicine and Nanobiotechnology Market Forecast
- 10.3.6 Australia Nanomedicine and Nanobiotechnology Market Forecast
- 10.4 Europe Nanomedicine and Nanobiotechnology Forecast by Country (2021-2026)
- 10.4.1 Germany Nanomedicine and Nanobiotechnology Market Forecast
- 10.4.2 France Nanomedicine and Nanobiotechnology Market Forecast
- 10.4.3 UK Nanomedicine and Nanobiotechnology Market Forecast
- 10.4.4 Italy Nanomedicine and Nanobiotechnology Market Forecast
- 10.4.5 Russia Nanomedicine and Nanobiotechnology Market Forecast
- 10.5 Middle East & Africa Nanomedicine and Nanobiotechnology Forecast by Region (2021-2026)
- 10.5.1 Egypt Nanomedicine and Nanobiotechnology Market Forecast
- 10.5.2 South Africa Nanomedicine and Nanobiotechnology Market Forecast
- 10.5.3 Israel Nanomedicine and Nanobiotechnology Market Forecast
- 10.5.4 Turkey Nanomedicine and Nanobiotechnology Market Forecast
- 10.5.5 GCC Countries Nanomedicine and Nanobiotechnology Market Forecast
- 10.6 Global Nanomedicine and Nanobiotechnology Forecast by Type (2021-2026)
- 10.7 Global Nanomedicine and Nanobiotechnology Forecast by Application (2021-2026)
11 Key Players Analysis
- 11.1 Abbott
- 11.1.1 Abbott Company Information
- 11.1.2 Abbott Nanomedicine and Nanobiotechnology Product Offered
- 11.1.3 Abbott Nanomedicine and Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
- 11.1.4 Abbott Main Business Overview
- 11.1.5 Abbott Latest Developments
- 11.2 GE Healthcare
- 11.2.1 GE Healthcare Company Information
- 11.2.2 GE Healthcare Nanomedicine and Nanobiotechnology Product Offered
- 11.2.3 GE Healthcare Nanomedicine and Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
- 11.2.4 GE Healthcare Main Business Overview
- 11.2.5 GE Healthcare Latest Developments
- 11.3 Johnson & Johnson
- 11.3.1 Johnson & Johnson Company Information
- 11.3.2 Johnson & Johnson Nanomedicine and Nanobiotechnology Product Offered
- 11.3.3 Johnson & Johnson Nanomedicine and Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
- 11.3.4 Johnson & Johnson Main Business Overview
- 11.3.5 Johnson & Johnson Latest Developments
- 11.4 Merck
- 11.4.1 Merck Company Information
- 11.4.2 Merck Nanomedicine and Nanobiotechnology Product Offered
- 11.4.3 Merck Nanomedicine and Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
- 11.4.4 Merck Main Business Overview
- 11.4.5 Merck Latest Developments
- 11.5 Pfizer
- 11.5.1 Pfizer Company Information
- 11.5.2 Pfizer Nanomedicine and Nanobiotechnology Product Offered
- 11.5.3 Pfizer Nanomedicine and Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
- 11.5.4 Pfizer Main Business Overview
- 11.5.5 Pfizer Latest Developments
- 11.6 CombiMatrix
- 11.6.1 CombiMatrix Company Information
- 11.6.2 CombiMatrix Nanomedicine and Nanobiotechnology Product Offered
- 11.6.3 CombiMatrix Nanomedicine and Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
- 11.6.4 CombiMatrix Main Business Overview
- 11.6.5 CombiMatrix Latest Developments
- 11.7 Celgene
- 11.7.1 Celgene Company Information
- 11.7.2 Celgene Nanomedicine and Nanobiotechnology Product Offered
- 11.7.3 Celgene Nanomedicine and Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
- 11.7.4 Celgene Main Business Overview
- 11.7.5 Celgene Latest Developments
- 11.8 Mallinckrodt
- 11.8.1 Mallinckrodt Company Information
- 11.8.2 Mallinckrodt Nanomedicine and Nanobiotechnology Product Offered
- 11.8.3 Mallinckrodt Nanomedicine and Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
- 11.8.4 Mallinckrodt Main Business Overview
- 11.8.5 Mallinckrodt Latest Developments
- 11.9 Sigma-Tau Pharmaceuticals
- 11.9.1 Sigma-Tau Pharmaceuticals Company Information
- 11.9.2 Sigma-Tau Pharmaceuticals Nanomedicine and Nanobiotechnology Product Offered
- 11.9.3 Sigma-Tau Pharmaceuticals Nanomedicine and Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
- 11.9.4 Sigma-Tau Pharmaceuticals Main Business Overview
- 11.9.5 Sigma-Tau Pharmaceuticals Latest Developments
- 11.10 Teva Pharmaceutical
- 11.10.1 Teva Pharmaceutical Company Information
Summary:
Get latest Market Research Reports on Nanomedicine and Nanobiotechnology. Industry analysis & Market Report on Nanomedicine and Nanobiotechnology is a syndicated market report, published as Global Nanomedicine and Nanobiotechnology Market Growth (Status and Outlook) 2021-2026. It is complete Research Study and Industry Analysis of Nanomedicine and Nanobiotechnology market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
